CMS discusses VBP's effects on Medicaid best price

In new guidance discussing the effects of future value-based pricing (VBP) arrangements on Medicaid best prices, CMS encouraged states and manufacturers to negotiate CMS-approved supplemental rebates that would be excluded from Medicaid best price.

Last

Read the full 342 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE